Haemonetics (HAE) Tops Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $108.73 +0.30%
Revenue Growth %: +5.5%
Financial Fact:
Net income: 0.38
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: +5.5%
Financial Fact:
Net income: 0.38
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q3 EPS of $0.84, $0.11 better than the analyst estimate of $0.73. Revenue for the quarter came in at $260 million versus the consensus estimate of $266.94 million.
GUIDANCE:
Haemonetics sees FY2022 EPS of $2.45-$2.55, versus the consensus of $2.53.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Endava CFO placed on leave amid accounting probe
- CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
